Comparison of combined, stepwise sequential, contingent, and integrated screening in 7292 high-risk pregnant women

Prenatal Diagnosis

Volumn 31, Issue 11, 2011, Pages 1077-1081

  Guanciali Franchi, Paolo ^a,b   Iezzi, Irene ^a,b   Palka, Chiara ^a,b   Matarrelli, Barbara ^b   Morizio, Elisena ^a,b   Calabrese, Giuseppe ^a,b   Benn, Peter ^c  

^a SPIRITO SANTO HOSPITAL   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Amniocentesis; Down syndrome; Genetic counselling; Maternal serum screening; Prenatal diagnosis

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; PROTEIN A;

ADOLESCENT; ADULT; ANEUPLOIDY; ARTICLE; COMPARATIVE STUDY; DIAGNOSTIC VALUE; DOWN SYNDROME; EDWARDS SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; HIGH RISK PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; AMNIOCENTESIS; ANEUPLOIDY; DOWN SYNDROME; FEMALE; FETAL DISEASES; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 80055083178     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2836     Document Type: Article

References (18)

1. Aagard-Tillery KM, Malone FD, Nybberg DA, et al. 2009. Role of second trimester genetic sonography after Down syndrome screening. Obstet Gynecol 114: 1189-1196.
2. Bahado-Singh RO, Argoti P. 2010. An overview of first-trimester screening for chromosomal abnormalities. Clin Lab Med 30: 545-555.
3. Benacerraf BR. 2010. The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice. Prenat Diagn 30: 644-652.
4. Benn PA, Borrell A, Crossley J, et al. 2011. Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society of Prenatal Diagnosis. Prenat Diagn 31: 519-522.
5. Benn PA, Campbell WA, Zelop CM, Ingardia C, Egan JF. 2007. Stepwise sequential screening for fetal aneuploidy. Am J Obstet Gynecol 197: 312.e1-312.e5.
6. Benn PA, Wright D, Cuckle H. 2005. Practical strategies in contingent sequential screening for Down syndrome. Prenat Diagn 25: 645-652.
7. Cuckle HS, Benn PA. 2010. Multi-marker maternal serum screening for chromosomal abnormalities. In Genetic Disorders of the Fetus: Diagnosis, Prevention and Treatment (6th edn), Milunsky A, Milunsky JM (eds). Wiley-Blackwell: Chichester.
8. Cuckle HS, Malone FD, Wright D, et al. 2008. Contingent screening for Down syndrome-results from the FaSTER trial. Prenat Diagn 28: 89-94.
9. Guanciali-Franchi P, Iezzi I, Matarrelli B, Morizio E, Calabrese G, Palka G. 2010. Effectiveness of crosstrimester test in selecting high-risk pregnant women to undergo invasive prenatal diagnosis. Prenat Diagn 30: 795-796.
10. Malone FD, Canick JA, Ball RH, et al. First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium, et al. 2005. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353: 2001-2011.
11. Palomaki GE, Haddow JE, Knight GJ, et al. 1995. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn 15: 713-723.
12. Palomaki GE, Neveux LM, Knight GJ, Haddow JE. 2003. Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers. Prenat Diagn 23: 243-247.
13. Shamshirsaz AA, Benn P, Egan JF. 2010. The role of second-trimester serum screening in the post-first-trimester screening era. Clin Lab Med 30: 667-676.
14. Sherod C, Sebire NJ, Soares W, Snijders RJ, Nicolaides KH. 1997. Prenatal diagnosis of trisomy 18 at the 10-14-week ultrasound scan. Ultrasound Obstet Gynecol 10: 387-390.
15. Tul N, Spencer K, Noble P, Chan C, Nicolaides K. 1999. Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 19: 1035-1042.
16. Wald NJ, Rudnicka AR, Bestwick JP. 2006. Sequential and contingent prenatal screening for Down syndrome. Prenat Diagn 26: 769-777.
17. Wald NJ, Watt HC, Hackshaw AK. 1999. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 341: 461-467.
18. Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K. 2004. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn 24: 762-766.